WAVE Life Sciences announces proposed public offering of ordinary shares

|By:, SA News Editor

WAVE Life Sciences (NASDAQ:WVE) commenced an underwritten public offering of its ordinary shares and also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares sold in the public offering on the same terms and conditions.

Jefferies, Leerink Partners and Mizuho Securities are acting as joint book-running managers for the offering.

Press Release